BioSpace News Archive

Pharm Country

Schrödinger’s Financing Round Increases to $110 Million With New Investor Support

The financing is expected to be used to advance the company’s computational platform, as well as expand Schrödinger’s therapeutic pipeline.

May 21, 2019
·
2 min read
·
Alex Keown
Business

Gotham Therapeutics and ZoBio Achieve Significant Milestone in Epitranscriptomic Drug Discovery Collaboration

Completion of Gene-to-Lead phase for first discovery project targeting METTL3/METTL14 complex.

May 21, 2019
·
4 min read
Ophthalmology: Horus Pharma distributes ILUVIEN® in France

Horus Pharma, an independent laboratory specialized in ophthalmology, announces that it is now making ILUVIEN® available to French patients. ILUVIEN is owned by Alimera Sciences, Inc. (US).

May 21, 2019
·
4 min read
Business

California and Illinois tennis players named recipients of 2019 Novo Nordisk Donnelly Award Scholarships

Scholarships support young tennis players with Diabetes; eight regional recipients also named

May 21, 2019
·
4 min read
Drug Development

First patient treated in DIAMOND study to evaluate if Veltassa® (patiromer) improves outcomes by enabling long-term use of essential RAASi therapy

Vifor Pharma announced that treatment of the first patient in their global phase-IIIb DIAMOND study has begun.

May 21, 2019
·
7 min read
Deals

Poxel Announces Participation at Two Upcoming Investor Conferences and Imeglimin Presentation at the Japanese Diabetes Society

POXEL S.A. announced that it will be featured as a presenting company at the Jefferies 2019 Global Healthcare Conference and the JMP Securities Life Sciences Conference.

May 21, 2019
·
3 min read
Deals

Essity Divests Partly Owned Company in Turkey

Essity is divesting its 50% stake in the partly owned company SCA Yildiz in Turkey to the other part owner Yildiz.

May 21, 2019
·
1 min read
Deals

Oncopeptides AB: INTERIM REPORT Q1 2019

The initiation of the filing process for melflufen in the US is a major milestone for Oncopeptides.

May 21, 2019
·
3 min read
Sofinnova Partners Launch MD Start III Medtech Acceleration Fund at €48M

Sofinnova Partners, a leading European venture capital firm specialized in Life Sciences, announced the launch of MD Start III, which closed above its original target of €40 million.

May 21, 2019
·
3 min read
Next-Gen Payment Card Form-Factors Now the New Hope to Stem Continued ASP Degradation

Interestingly, between 2017 and 2018, there was a significant slowdown in contactless migration, driven by stagnation in the key contactless market, China.

May 21, 2019
·
4 min read